PT - JOURNAL ARTICLE AU - Salibi, Noura AU - Abdulrahim, Sawsan AU - Haddad, Maria El AU - Zeid, Berthe Abi AU - Alawieh, Marwan F. AU - Ramadan, Zeinab AU - Ghattas, Hala AU - McCall, Stephen J. TI - Predicting intention to vaccinate against COVID-19 in older Syrian refugees in Lebanon: findings from a multi-wave study AID - 10.1101/2022.07.23.22277948 DP - 2022 Jan 01 TA - medRxiv PG - 2022.07.23.22277948 4099 - http://medrxiv.org/content/early/2022/07/24/2022.07.23.22277948.short 4100 - http://medrxiv.org/content/early/2022/07/24/2022.07.23.22277948.full AB - Introduction COVID-19 vaccine acceptance among refugees in the Arab region remains low. This study aimed to examine the prevalence, reasons and predictors of COVID-19 vaccine refusal among older Syrian refugees in Lebanon.Method A nested cross-sectional study among older Syrian refugees in Lebanon. The sampling frame was a complete listing of beneficiary households of a humanitarian organization with an adult aged 50 years or older. Telephone surveys were completed between September 2020 and May 2021. Logistic regression models were used to identify predictors of COVID-19 vaccine refusal. Models were internally validated using bootstrap methods and the models’ calibration and discrimination were presented.Results Of 3,173 Syrian refugees, 61% intended to receive the COVID-19 vaccine, 31% refused and 7% were undecided. Reasons for vaccine refusal were: preference to follow preventive measures (27%) and belief that the vaccine is not essential (21%). Despite high vaccine acceptance, only 6% of older Syrian refugees were registered on the national platform to receive the vaccine. Reasons for not registering included: being unsure about how to register (36%), and not wanting to receive the vaccine (33%). Predictors of COVID-19 vaccine refusal included: sex (female), older age, education, living outside informal tented settlements, perceiving COVID-19 as not severe and vaccines as not safe or effective, and using social media for information on COVID-19. After adjusting for optimization, the final model showed moderate discrimination (C-statistic: 0.65 (95% CI:(0.63-0.67)) and good calibration (C-Slope: 0.93 (95% CI:0.82-1.06)).Conclusion This study developed predictive model for vaccination intention with a moderate discriminative ability and good calibration. Prediction models in humanitarian settings can help to identify refugees at higher risk of not intending to receive the COVID-19 vaccine for public health targeting.What is already known on this topic Despite global efforts towards more inclusive national deployment vaccination plans, vaccine coverage and uptake among migrants and refugees remains low. Refugees and migrants, the majority of whom live in low and middle income countries, bear the double burden of vaccine inequity and face several challenges and barriers to vaccination including low vaccine supply, inability to access health services, fear of arrest and deportation, lack of accessible information as well as other language, and economic barriers. Research on COVID-19 vaccine intentions among refugees in the region has been limited. Understanding intentions and predictors to vaccinate among refugees, and addressing barriers to vaccine acceptance and registration, is crucial to ensure equitable vaccination and coverage, reduce the spread of COVID-19 and achieve herd immunity.What this study adds This study is one of the first to develop and internally validate a model of intention to refuse vaccination against COVID-19 in older Syrian refugees. Predictors of intention to refuse the vaccine include age, education, living outside informal tented settlements, sex, perceiving COVID-19 as not a serious infection and vaccines as not safe or effective, and using social media as a source of information on COVID-19. The primary reasons for vaccine refusal were: preference to follow preventive measures, concerns that the vaccine is too new, and belief that the vaccine is not essential. Registration on the national platform to receive the vaccine was low and the reasons for not registering included: being unsure about how to register, and not wanting to receive the vaccine.How this study might affect research, practice or policy This study highlights the need for targeted interventions to enhance vaccine acceptance and uptake among older Syrian refugees, and address barriers to vaccine registration. Predictors of COVID-19 vaccine refusal among older Syrian refugees will inform humanitarian programming and public health campaigns, and guide resource allocation and deployment planning. Findings inform future research to better understand the predictors of vaccine refusal.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by ELRHA's Research for Health in Humanitarian Crisis (R2HC) Programme, which aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises. R2HC is funded by the UK Foreign, Commonwealth and Development Office (FCDO), Wellcome, and the UK National Institute for Health Research (NIHR). The views expressed herein should not be taken, in any way, to reflect the official opinion of the NRC or ELRHA. The funding agency was not involved in the data collection, analysis or interpretation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the Social and Behavioral Sciences Institutional Review Board (SBS-IRB) at the American University of Beirut gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors